 MedPage Today |
HBV Screening Hit or Miss in Rituximab Users
MedPage Today ATLANTA — At least in one academic medical center, half of cancer patients on rituximab (Rituxan) were not screened for hepatitis B virus (HBV) infection as recommended, a researcher said here. A review of patients’ charts at UMass Memorial Health … |
|
Rituximab and 131iodine-tositumomab produce similar survival for follicular …
Curetoday.com (press release) NEW YORK (Reuters Health) – Added to standard CHOP chemotherapy, both rituximab and radioimmunotherapy (RIT) produce excellent results in patients presenting with advanced follicular lymphoma, a Southwest Oncology Group study shows. “My view of … |
|
Rituximab and 131iodine-tositumomab produce similar survival for follicular …
ModernMedicine NEW YORK (Reuters Health) – Added to standard CHOP chemotherapy, both rituximab and radioimmunotherapy (RIT) produce excellent results in patients presenting with advanced follicular lymphoma, a Southwest Oncology Group study shows. “My view of … |
|
Older and younger chronic leukemia patients may need different therapy
Science Codex “The study suggests that chlorambucil is superior to fludarabine in older patients, and that CD20 antibody therapies such as rituximab are beneficial as front-line therapy for all CLL patients, regardless of age,” says Byrd, who is the D. Warren Brown … |
|
New Combo Replaces CHOP for Lymphoma
MedPage Today ATLANTA – Once the most common treatment for indolent non-Hodgkin’s Lymphoma, the combination chemotherapy known as CHOP is rapidly falling to the wayside in Germany – replaced by bendamustine (Treanda), frequently combined with rituximab … |
|
Anti–PD-1 Immunotherapy Shows Activity in Relapsed Lymphoma Patients
Cancer Network The combination of rituximab (Rituxan) and the novel immunotherapy pidilizumab (CT-011) is both active and well tolerated in follicular lymphoma patients, according to results of a phase II trial presented by Jason R. Westin, MD, of the MD Anderson … |
|
Older and younger chronic leukemia patients may need different therapy
Medical Xpress “The study suggests that chlorambucil is superior to fludarabine in older patients, and that CD20 antibody therapies such as rituximab are beneficial as front-line therapy for all CLL patients, regardless of age,” says Byrd, who is the D. Warren Brown … |
 HealthNewsDigest.com |
Older and Younger Chronic Leukemia Patients May Need Different Therapy
HealthNewsDigest.com “The study suggests that chlorambucil is superior to fludarabine in older patients, and that CD20 antibody therapies such as rituximab are beneficial as front-line therapy for all CLL patients, regardless of age,” says Byrd, who is the D. Warren Brown … |
Search in our News ChannelsPipelineReview.com (press release)The presented data included two Phase II trials on the combination of lenalidomide with R-CHOP, a Phase I/II trial evaluating the combination of lenalidomide and ofatumumab, and a Phase II tr…
|
Celgene Int’l Sàrl Announces Results From Several Studies – Quick Facts
RTT News The presented data included two Phase II trials on the combination of lenalidomide with R-CHOP, a Phase I/II trial evaluating the combination of lenalidomide and ofatumumab, and a Phase II trial analyzing the combination of lenalidomide and rituximab. |